ConductScience.org, home

Paper42409802

Intratumoral microbiota in tumorigenesis: A double-edged sword.

Fu X and 16 others. Chin Med J (Engl), 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Intratumoral microbiota in tumorigenesis: A double-edged sword. Papers, record 42409802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42409802

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Intratumoral microbiota in tumorigenesis: A double-edged sword.
PubMed
Journal
Chin Med J (Engl)
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-23
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fu XXinyue
2Chen HHao
3Du MMeihang
4Li PPeiheng
5Zhao YYue
6Yang HHuanzuo
7Li HHancong
8Zhang GGongshuang
9He PPuxing
10Wu SShuang
11Zhang MMiao
12An ZZhenmei
13Li ZZhihui
14Ying BBinwu
15Silva JRHJuan Rául Hernandez
16An LLiwei
17Luo HHan

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MicrobiotaMajor topic
CarcinogenesisMajor topic
NeoplasmsMajor topic
Humans
Animals
Tumor Microenvironment

References145

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138379784Helicobacter pylori and immunotherapy for gastrointestinal cancer.Innovation (Camb)2024https://conductscience.org/library/papers/38379784PubMed
231494531Diminishing microbiome richness and distinction in the lower respiratory tract of lung cancer patients: A multiple comparative study design with independent validation.Lung Cancer2019https://conductscience.org/library/papers/31494531PubMed
332291445The gut microbial metabolite trimethylamine N-oxide aggravates GVHD by inducing M1 macrophage polarization in mice.Blood2020https://conductscience.org/library/papers/32291445PubMed
439423813Vaginal lactobacilli produce anti-inflammatory β-carboline compounds.Cell Host Microbe2024https://conductscience.org/library/papers/39423813PubMed
531578522The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL.Nature2019https://conductscience.org/library/papers/31578522PubMed
634298645Micro- and Mycobiota Dysbiosis in Pancreatic Ductal Adenocarcinoma Development.Cancers (Basel)2021https://conductscience.org/library/papers/34298645PubMed
730833345Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1.EMBO Rep2019https://conductscience.org/library/papers/30833345PubMed
829567829The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression.Cancer Discov2018https://conductscience.org/library/papers/29567829PubMed
939554831
Interconnection of the Gut-Skin Axis in NC/Nga Mouse with Atopic Dermatitis: Effects of the Three Types of Bifidobacterium bifidum CBT-BF3 (Probiotics, Postbiotics, and Cytosine-Phosphate-Guanine Oligodeoxynucleotide) on T Cell Differentiation and Gut Microbiota.
Food Sci Anim Resour2024https://conductscience.org/library/papers/39554831PubMed
1037904102Lactobacillus casei combined with Lactobacillus reuteri alleviate pancreatic cancer by inhibiting TLR4 to promote macrophage M1 polarization and regulate gut microbial homeostasis.BMC Cancer2023https://conductscience.org/library/papers/37904102PubMed
1140074904Structure and mechanism of the plastid/parasite ATP/ADP translocator.Nature2025https://conductscience.org/library/papers/40074904PubMed
1233303685Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients.Science2021https://conductscience.org/library/papers/33303685PubMed
1326764597Structural Insights into Polymorphic ABO Glycan Binding by Helicobacter pylori.Cell Host Microbe2016https://conductscience.org/library/papers/26764597PubMed
1436195972Bifidobacterium spp. and their metabolite lactate protect against acute pancreatitis via inhibition of pancreatic and systemic inflammatory responses.Gut Microbes2022https://conductscience.org/library/papers/36195972PubMed
1536917951B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity.Cancer Cell2023https://conductscience.org/library/papers/36917951PubMed
1623954158Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin.Cell Host Microbe2013https://conductscience.org/library/papers/23954158PubMed
1724421902Microbial dysbiosis is associated with human breast cancer.PLoS One2014https://conductscience.org/library/papers/24421902PubMed
1836557635Akkermansia muciniphila and Faecalibacterium prausnitzii in Immune-Related Diseases.Microorganisms2022https://conductscience.org/library/papers/36557635PubMed
1934743032The oral microbiota and its role in carcinogenesis.Semin Cancer Biol2022https://conductscience.org/library/papers/34743032PubMed
2034536504Microbiota and prostate cancer.Semin Cancer Biol2022https://conductscience.org/library/papers/34536504PubMed

See all 145 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42409802

GET https://conductscience.org/api/papers/v1/42409802/references?page=2